Samy Tadros
Corporate Officer/Principal presso TANGO THERAPEUTICS, INC.
Profilo
Samy Tadros is currently the Head of Business Development at Tango Therapeutics, Inc. Prior to his current position, he worked at Celgene Corp.
as the Executive Director of Business Development from 2009 to 2020.
Mr. Tadros holds an undergraduate degree from Concordia University Chicago, an MBA from Fairleigh Dickinson University, and a graduate degree from Temple University School of Pharmacy.
Posizioni attive di Samy Tadros
| Società | Posizione | Inizio |
|---|---|---|
| TANGO THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Precedenti posizioni note di Samy Tadros
| Società | Posizione | Fine |
|---|---|---|
| CELGENE | Corporate Officer/Principal | 01/04/2020 |
Formazione di Samy Tadros
| Concordia University Chicago | Undergraduate Degree |
| Temple University School of Pharmacy | Graduate Degree |
| Fairleigh Dickinson University | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| TANGO THERAPEUTICS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
- Borsa valori
- Insiders
- Samy Tadros
